Head to Head Contrast: Medical Cannabis Payment Solutions (OTCMKTS:REFG) and Fidelity National Information Services (NYSE:FIS)

Medical Cannabis Payment Solutions (OTCMKTS:REFG) and Fidelity National Information Services (NYSE:FIS) are both business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability.

Valuation & Earnings

This table compares Medical Cannabis Payment Solutions and Fidelity National Information Services”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medical Cannabis Payment Solutions	N/A	N/A	N/A	N/A	N/A
Fidelity National Information Services	$10.68 billion	2.03	$382.00 million	$5.16	8.14

Fidelity National Information Services has higher revenue and earnings than Medical Cannabis Payment Solutions.

Profitability

This table compares Medical Cannabis Payment Solutions and Fidelity National Information Services’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Medical Cannabis Payment Solutions	N/A	N/A	N/A
Fidelity National Information Services	23.35%	21.30%	8.60%

Institutional and Insider Ownership

96.2% of Fidelity National Information Services shares are owned by institutional investors. 0.3% of Fidelity National Information Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Medical Cannabis Payment Solutions and Fidelity National Information Services, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medical Cannabis Payment Solutions	0	0	0	0	0.00
Fidelity National Information Services	2	9	13	0	2.46

Fidelity National Information Services has a consensus target price of $59.96, indicating a potential upside of 42.79%. Given Fidelity National Information Services’ stronger consensus rating and higher possible upside, analysts clearly believe Fidelity National Information Services is more favorable than Medical Cannabis Payment Solutions.

Volatility & Risk

Medical Cannabis Payment Solutions has a beta of -0.98, indicating that its stock price is 198% less volatile than the S&P 500. Comparatively, Fidelity National Information Services has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500.

Summary

Fidelity National Information Services beats Medical Cannabis Payment Solutions on 10 of the 10 factors compared between the two stocks.

About Medical Cannabis Payment Solutions

Medical Cannabis Payment Solutions, Inc. develops and markets a payment system for medical cannabis transactions. Its solution assists in the state tracking of sales, collection of tax, and supervision of sales to consumers. The company was incorporated in 2013 and is based in Cheyenne, Wyoming. On August 12, 2024, Medical Cannabis Payment Solutions, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Western District of Pennsylvania.

About Fidelity National Information Services

Fidelity National Information Services, Inc. engages in the provision of financial services technology solutions for financial institutions, businesses, and developers worldwide. It operates through Banking Solutions, Capital Market Solutions, and Corporate and Other segments. The company provides core processing and ancillary applications; mobile and online banking; fraud, risk management, and compliance; card and retail payment; electronic funds transfer and network; wealth and retirement; and item processing and output solutions. It also offers trading and asset, lending, leveraged and syndicated loan markets, and treasury and risk solutions. The company was founded in 1968 and is headquartered in Jacksonville, Florida.